ELAB (elevaiskincare.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Elevai Labs Inc (ELAB)

Elevai Labs Inc. management is focused on expanding regenerative technologies through a network of aesthetic clinics. Scientific potential in the field of exosomes ensures leadership in cosmeceuticals, while revenue growth confirms the successful scaling of the business. The market-to-book ratio on the GURU.Markets daily chart demonstrates current asset adaptability, where the 0.10 mark reflects the company's current valuation.

ELAB Elevai Corp: Nilai Pasar marang Nilai Buku ing interval 07.04.2024 - 28.10.2026

Rincian metrik keuangan lan pasar Elevai Labs Inc (ELAB)

- rega lan prakiraan konsensus rega:
Rega saham Elevai Labs Inc.|ELAB - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Elevai Skincare|ELAB - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Elevai Labs|ELAB - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku elevaiskincare.com|ELAB - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Elevai Labs Inc.|ELAB - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Elevai Skincare|ELAB - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Elevai Skincare|ELAB - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Elevai Labs
Analisis wiwitan perusahaan:Elevai Labs Inc. - ELAB
Produk asli Elevai Skincare

Investors seek a balance between the intrinsic value of assets and market expectations. This ratio compares current market capitalization to the net book value, revealing either overvaluation or a hidden crisis. For Elevai Labs Inc. (ELAB), with its narrow specialization in exosomes, this metric reflects market confidence in a single-product model. Diversification into aesthetic medicine should stabilize the historical market-to-book value ratio.

Pesaing utama

Krystal Biotech, Inc. (KRYS) - Rasio Kapitalisasi Pasar marang Nilai Buku|APGE (apogeetherapeutics.com) - Rasio Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Arcutis Biotherapeutics, Inc. ARQT|Kapitalisasi Pasar marang Aset Bersih Vericel Corp|Oruka Corp (ORKA) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku sanaramedtech.com (SMTI)|Rasio Kapitalisasi Pasar marang Nilai Buku DBVT (DBV Technologies)|Solesence Beauty - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Journey Medical Corp. (DERM)|FBRX: Nilai Pasar marang Nilai Buku|EMPG (Empro) - Rasio Nilai Pasar marang Nilai Buku|Sol-Gel Technologies, Ltd. (SLGL) - Rasio Kapitalisasi marang Aset Bersih|AXIL (AXIL Brands Inc) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku medicuspharma.com (MDCX)|Verrica Pharmaceuticals (VRCA) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku HOTH (hoththerapeutics.com)|Rasio Nilai Pasar marang Nilai Buku BFRI|VYNE Therapeutics, Inc. - Kapitalisasi Pasar marang Nilai Buku|Sonoma Pharma - Rasio Nilai Pasar marang Nilai Buku|QNRX - Rasio Kapitalisasi Pasar marang Nilai Buku|Azitra - Rasio Kapitalisasi Pasar marang Nilai Buku|DRMA (Dermata Therapeutics Inc) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Revance Therapeutics, Inc (RVNC)